Alnylam Pharmaceuticals (ALNY) Times Interest Earned (2020 - 2026)
Alnylam Pharmaceuticals posted quarterly Times Interest Earned of $3.88 for Q1 2026, up 1150.63% year-on-year from $0.31 in Q1 2025, and up 92.51% on a QoQ basis from $2.01 in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 7 years of Times Interest Earned data on file, last reported at $3.88 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 1150.63% year-over-year to $3.88; the trailing twelve-month figure through Mar 2026 stood at $3.43 (up 590.18% YoY), and the FY2025 full-year result was $1.99, up 259.23% from the prior year.
- Times Interest Earned for Q1 2026 stood at $3.88, up from $2.01 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8.29 in Q3 2025 and bottomed at -$7.65 in Q2 2023.
- The 5-year median for Times Interest Earned is -$2.24 (2024), against an average of -$1.22.
- The widest annual swing landed in 2024, when Times Interest Earned tumbled 132.32%; it then surged 1150.63% in 2026.
- A 5-year view of Times Interest Earned shows it stood at -$6.31 in 2022, then jumped by 41.09% to -$3.71 in 2023, then increased by 27.35% to -$2.7 in 2024, then jumped by 174.64% to $2.01 in 2025, then surged by 92.51% to $3.88 in 2026.
- The last three Times Interest Earned figures came in at $3.88 (Q1 2026), $2.01 (Q4 2025), and $8.29 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -36.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.88 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | 8.29 |
| Jun 30, 2025 | -0.40 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | -2.70 |
| Sep 30, 2024 | -2.24 |
| Jun 30, 2024 | 1.46 |
| Mar 31, 2024 | -1.23 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | 6.92 |
| Jun 30, 2023 | -7.65 |
| Mar 31, 2023 | -5.17 |
| Dec 31, 2022 | -6.31 |
| Sep 30, 2022 | -6.28 |
| Jun 30, 2022 | -4.50 |
| Mar 31, 2022 | -3.46 |
| Dec 31, 2021 | -5.28 |
| Sep 30, 2021 | -4.51 |
| Jun 30, 2021 | -4.37 |
| Mar 31, 2021 | -5.73 |
| Dec 31, 2020 | -6.81 |
| Sep 30, 2020 | -7.84 |
| Jun 30, 2020 | -7.30 |